HK1210160A1 - Novel compounds for regeneration of terminally-differentiated cells and tissues - Google Patents

Novel compounds for regeneration of terminally-differentiated cells and tissues

Info

Publication number
HK1210160A1
HK1210160A1 HK15110946.7A HK15110946A HK1210160A1 HK 1210160 A1 HK1210160 A1 HK 1210160A1 HK 15110946 A HK15110946 A HK 15110946A HK 1210160 A1 HK1210160 A1 HK 1210160A1
Authority
HK
Hong Kong
Prior art keywords
terminally
regeneration
tissues
novel compounds
differentiated cells
Prior art date
Application number
HK15110946.7A
Other languages
English (en)
Chinese (zh)
Inventor
Michael Bs
Original Assignee
Acousia Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acousia Therapeutics Gmbh filed Critical Acousia Therapeutics Gmbh
Publication of HK1210160A1 publication Critical patent/HK1210160A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK15110946.7A 2013-11-12 2015-11-06 Novel compounds for regeneration of terminally-differentiated cells and tissues HK1210160A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13192475.5A EP2871181B1 (fr) 2013-11-12 2013-11-12 Nouveaux composés pour la régénération de cellules et de tissus terminalement différenciés

Publications (1)

Publication Number Publication Date
HK1210160A1 true HK1210160A1 (en) 2016-04-15

Family

ID=49578155

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110946.7A HK1210160A1 (en) 2013-11-12 2015-11-06 Novel compounds for regeneration of terminally-differentiated cells and tissues

Country Status (9)

Country Link
US (1) US20160280670A1 (fr)
EP (1) EP2871181B1 (fr)
JP (1) JP2016535743A (fr)
CN (1) CN105814027A (fr)
AU (1) AU2014350358A1 (fr)
CA (1) CA2928793A1 (fr)
ES (1) ES2607752T3 (fr)
HK (1) HK1210160A1 (fr)
WO (1) WO2015071165A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3366683A1 (fr) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Amides, acetamides et ureas cycliques pour ouvris les voies de calcium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ571826A (en) * 2006-04-11 2012-01-12 Novartis Ag HCV/HIV inhibitors and their uses
DE102010007281A1 (de) * 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger

Also Published As

Publication number Publication date
US20160280670A1 (en) 2016-09-29
WO2015071165A1 (fr) 2015-05-21
CA2928793A1 (fr) 2015-05-21
AU2014350358A1 (en) 2016-04-28
JP2016535743A (ja) 2016-11-17
CN105814027A (zh) 2016-07-27
ES2607752T3 (es) 2017-04-03
EP2871181B1 (fr) 2016-10-05
EP2871181A1 (fr) 2015-05-13

Similar Documents

Publication Publication Date Title
ZA202006429B (en) Methods of using zscan4 for rejuvenating human cells
HK1208439A1 (en) 5-azaindazole compounds and methods of use 5-
HK1220382A1 (zh) 用於保護皮膚的化合物
SG11201600707QA (en) Substituted aminopyrimidine compounds and methods of use
HK1210704A1 (en) Compositions for sensitive skin
HK1201521A1 (en) Heterocyclic compounds and methods for their use
HRP20181710T1 (hr) Uporaba derivata benzimidazol-prolina
HK1201533A1 (en) Heterocyclic compounds and methods for their use
HK1201531A1 (en) Heterocyclic compounds and methods for their use
EP3033099A4 (fr) Régénération d'un tissu lésé
IL244026A0 (en) wnt preparations and purification methods
SG11201508879XA (en) Skin cleansing composition
SG11201508529RA (en) Skin cleansing composition
GB201309375D0 (en) Medical methods and compounds for medical use
HK1210160A1 (en) Novel compounds for regeneration of terminally-differentiated cells and tissues
EP3006054A4 (fr) Matériau pour régénération de tissu parodontal
HK1217286A1 (zh) 含有人參皂苷 的皮膚外用劑組合物
AU2013903092A0 (en) Regeneration of damaged tissue
GB201313566D0 (en) Regenerative epidermis
GB201309376D0 (en) Medical methods and compounds for medical use
GB201309379D0 (en) Medical methods and compounds for medical use
GB201322425D0 (en) Novel compounds and improved treatemtns for glaucoma